Literature DB >> 20664055

Essential role for focal adhesion kinase in regulating stress hematopoiesis.

Sasidhar Vemula1, Baskar Ramdas, Philip Hanneman, Joseph Martin, Hilary E Beggs, Reuben Kapur.   

Abstract

Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that has been extensively studied in fibroblasts; however its function in hematopoiesis remains an enigma. FAK is thought to be expressed in myeloid and erythroid progenitors, and its expression is enhanced in response to cytokines such as granu-locyte macrophage colony-stimulating factor. Furthermore, bone marrow cells cultured in granulocyte macrophage colony-stimulating factor show active migration and chemoattractant-induced polarization, which correlates with FAK induction. While loss of FAK in mice results in embryonic lethality, we have deleted FAK in the adult bone marrow. We show an essential role for FAK in regulating hemolytic, myelotoxic, as well as acute inflammatory stress responses in vivo. In vitro, loss of FAK in erythroid and myeloid progenitor's results in impaired cytokine induced growth and survival, as well as defects in the activation and expression of antiapoptotic proteins caspase 3 and Bcl-x(L). Additionally, reduced migration and adhesion of myeloid cells on extracellular matrix proteins, as well as impaired activation of Rac GTPase is also observed in the absence of FAK. Our studies reveal an essential role for FAK in integrating growth/survival and adhesion based functions in myeloid and erythroid cells predominantly under conditions of stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20664055      PMCID: PMC2993618          DOI: 10.1182/blood-2010-01-262790

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

1.  FERM domain interaction promotes FAK signaling.

Authors:  Jill M Dunty; Veronica Gabarra-Niecko; Michelle L King; Derek F J Ceccarelli; Michael J Eck; Michael D Schaller
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

2.  Distinct roles of Mdm2 and Mdm4 in red cell production.

Authors:  Marion Maetens; Gilles Doumont; Sarah De Clercq; Sarah Francoz; Pascal Froment; Eric Bellefroid; Ursula Klingmuller; Guillermina Lozano; Jean-Christophe Marine
Journal:  Blood       Date:  2006-11-14       Impact factor: 22.113

3.  Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation.

Authors:  Ssang-Taek Lim; Xiao Lei Chen; Yangmi Lim; Dan A Hanson; Thanh-Trang Vo; Kyle Howerton; Nicholas Larocque; Susan J Fisher; David D Schlaepfer; Dusko Ilic
Journal:  Mol Cell       Date:  2008-01-18       Impact factor: 17.970

4.  Focal adhesion kinase regulates pathogen-killing capability and life span of neutrophils via mediating both adhesion-dependent and -independent cellular signals.

Authors:  Anongnard Kasorn; Pilar Alcaide; Yonghui Jia; Kulandayan K Subramanian; Bara Sarraj; Yitang Li; Fabien Loison; Hidenori Hattori; Leslie E Silberstein; William F Luscinskas; Hongbo R Luo
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

5.  Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion.

Authors:  Shu-Yi Chen; Hong-Chen Chen
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

6.  Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout.

Authors:  Ian S Hitchcock; Norma E Fox; Nicolas Prévost; Katherine Sear; Sanford J Shattil; Kenneth Kaushansky
Journal:  Blood       Date:  2007-10-09       Impact factor: 22.113

7.  Granulocyte colony-stimulating factor delays neutrophil apoptosis by inhibition of calpains upstream of caspase-3.

Authors:  Bram J van Raam; Agata Drewniak; Vincent Groenewold; Timo K van den Berg; Taco W Kuijpers
Journal:  Blood       Date:  2008-06-04       Impact factor: 22.113

8.  A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis.

Authors:  Valter Agosti; Vinit Karur; Pradeep Sathyanarayana; Peter Besmer; Don M Wojchowski
Journal:  Exp Hematol       Date:  2008-12-18       Impact factor: 3.084

9.  Impaired integrin-mediated signal transduction, altered cytoskeletal structure and reduced motility in Hck/Fgr deficient macrophages.

Authors:  P W Suen; D Ilic; E Caveggion; G Berton; C H Damsky; C A Lowell
Journal:  J Cell Sci       Date:  1999-11       Impact factor: 5.285

10.  Regulation of lamellipodial persistence, adhesion turnover, and motility in macrophages by focal adhesion kinase.

Authors:  Katherine A Owen; Fiona J Pixley; Keena S Thomas; Miguel Vicente-Manzanares; Brianne J Ray; Alan F Horwitz; J Thomas Parsons; Hilary E Beggs; E Richard Stanley; Amy H Bouton
Journal:  J Cell Biol       Date:  2007-12-10       Impact factor: 10.539

View more
  21 in total

1.  SWAP-70 regulates erythropoiesis by controlling α4 integrin.

Authors:  Tatsiana Ripich; Rolf Jessberger
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

2.  Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis.

Authors:  Anindya Chatterjee; Joydeep Ghosh; Baskar Ramdas; Raghuveer Singh Mali; Holly Martin; Michihiro Kobayashi; Sasidhar Vemula; Victor H Canela; Emily R Waskow; Valeria Visconte; Ramon V Tiu; Catherine C Smith; Neil Shah; Kevin D Bunting; H Scott Boswell; Yan Liu; Rebecca J Chan; Reuben Kapur
Journal:  Cell Rep       Date:  2014-11-13       Impact factor: 9.423

3.  ROCK1 functions as a critical regulator of stress erythropoiesis and survival by regulating p53.

Authors:  Sasidhar Vemula; Jianjian Shi; Raghuveer Singh Mali; Peilin Ma; Yan Liu; Philip Hanneman; Karl R Koehler; Eri Hashino; Lei Wei; Reuben Kapur
Journal:  Blood       Date:  2012-08-13       Impact factor: 22.113

Review 4.  β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies.

Authors:  Stefano Rivella
Journal:  Haematologica       Date:  2015-04       Impact factor: 9.941

5.  Cytopenia induction by 5-fluorouracil identifies thrombopoietic mutants in sensitized ENU mutagenesis screens.

Authors:  Nicole M Anderson; Zorana Berberovic; Elizabeth Berndl; Monica L Bailey; Ann M Flenniken; Lucy R Osborne; S Lee Adamson; Janet Rossant; Chen Wang; Mark D Minden; Kelly M McNagny; Robert F Paulson; Dwayne L Barber; William L Stanford
Journal:  Exp Hematol       Date:  2011-09-14       Impact factor: 3.084

6.  Fak depletion in both hematopoietic and nonhematopoietic niche cells leads to hematopoietic stem cell expansion.

Authors:  Jiayun Lu; Yan Sun; Cesar Nombela-Arrieta; Karrie P Du; Shin-Young Park; Li Chai; Carl Walkley; Hongbo R Luo; Leslie E Silberstein
Journal:  Exp Hematol       Date:  2011-12-08       Impact factor: 3.084

Review 7.  β-Thalassemia and Polycythemia vera: targeting chronic stress erythropoiesis.

Authors:  Bart J Crielaard; Stefano Rivella
Journal:  Int J Biochem Cell Biol       Date:  2014-04-06       Impact factor: 5.085

8.  Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABL.

Authors:  Raghuveer Singh Mali; Baskar Ramdas; Peilin Ma; Jianjian Shi; Veerendra Munugalavadla; Emily Sims; Lei Wei; Sasidhar Vemula; Sarah C Nabinger; Charles B Goodwin; Rebecca J Chan; Fabiola Traina; Valeria Visconte; Ramon V Tiu; Timothy A Lewis; Andrew M Stern; Qiang Wen; John D Crispino; H Scott Boswell; Reuben Kapur
Journal:  Cancer Cell       Date:  2011-09-13       Impact factor: 31.743

Review 9.  FAK in cancer: mechanistic findings and clinical applications.

Authors:  Florian J Sulzmaier; Christine Jean; David D Schlaepfer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

10.  Erythroid cells generated in the absence of specific β1-integrin heterodimers accumulate reactive oxygen species at homeostasis and are unable to mount effective antioxidant defenses.

Authors:  Tatyana Ulyanova; Yi Jiang; Steven M Padilla; Thalia Papayannopoulou
Journal:  Haematologica       Date:  2013-06-28       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.